Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003020917 | SCV003301817 | pathogenic | Agammaglobulinemia 4, autosomal recessive | 2022-07-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with BLNK-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val9Alafs*7) in the BLNK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLNK are known to be pathogenic (PMID: 10583958, 24582315). |